Literature DB >> 4014051

Pathophysiology of congestive heart failure.

W W Parmley.   

Abstract

Congestive heart failure is a syndrome that can be caused by a variety of abnormalities, including pressure and volume overload, loss of muscle, primary muscle disease or excessive peripheral demands such as high output failure. In the usual form of heart failure, the heart muscle has reduced contractility. This produces a reduction in cardiac output, which then becomes inadequate to meet the peripheral demands of the body. The 4 primary determinants of left ventricular (LV) performance are generally altered as follows: (1) There is an intrinsic decrease in muscle contractility. (2) Preload or left atrial filling pressure is increased, resulting in pulmonary congestion and dyspnea. (3) Although systemic blood pressure is often reduced, there is an increase in systemic vascular resistance (afterload), which can further reduce cardiac output. (4) Heart rate is generally increased as part of a compensatory mechanism associated with an increase in sympathetic tone and circulating catecholamines. In patients with coronary disease, there is often an imbalance between myocardial oxygen supply and demand. An increase in heart size may be particularly deleterious by increasing wall tension because of the Laplace relation and increasing myocardial oxygen consumption.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1985        PMID: 4014051     DOI: 10.1016/0002-9149(85)91199-3

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  10 in total

Review 1.  Aspirin and ACE-inhibitors: for wedding or funeral?

Authors:  I M Barbash; S Gottlieb; U Goldbourt; S Behar; J Leor
Journal:  J Thromb Thrombolysis       Date:  2001-04       Impact factor: 2.300

Review 2.  The angiotensin-converting enzyme inhibitor and aspirin interaction in congestive heart failure: fear or reality?

Authors:  R Moskowitz
Journal:  Curr Cardiol Rep       Date:  2001-05       Impact factor: 2.931

Review 3.  Renal excretory responses to single and repeated administration of diuretics in healthy subjects: clinical connotations.

Authors:  A J Reyes; W P Leary
Journal:  Cardiovasc Drugs Ther       Date:  1993-01       Impact factor: 3.727

4.  A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function.

Authors:  F J Giordano; H P Gerber; S P Williams; N VanBruggen; S Bunting; P Ruiz-Lozano; Y Gu; A K Nath; Y Huang; R Hickey; N Dalton; K L Peterson; J Ross; K R Chien; N Ferrara
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-01       Impact factor: 11.205

5.  A cardiovascular-respiratory control system model including state delay with application to congestive heart failure in humans.

Authors:  Jerry J Batzel; Franz Kappel; Susanne Timischl-Teschl
Journal:  J Math Biol       Date:  2004-10-07       Impact factor: 2.259

Review 6.  B-type natriuretic peptide and renal disease.

Authors:  Peter A McCullough; Keisha R Sandberg
Journal:  Heart Fail Rev       Date:  2003-10       Impact factor: 4.214

7.  Effect of dehydration and hyperosmolal hydration on lignocaine and metabolites disposition in conscious rabbits.

Authors:  M Chamelian; A Lécrivain; A Robichaud; P du Souich
Journal:  Br J Pharmacol       Date:  1994-09       Impact factor: 8.739

8.  Cell therapy rescues aging-induced beta-1 adrenergic receptor and GRK2 dysfunction in the coronary microcirculation.

Authors:  Gabrielle Rowe; Evan Tracy; Jason E Beare; Amanda J LeBlanc
Journal:  Geroscience       Date:  2021-10-04       Impact factor: 7.713

9.  Arterial-renal Syndrome in Patients with ESRD, a New Disease Paradigm.

Authors:  Jake Goldstein; Robert S Dieter; Vinod Bansal; Keaton Wieschhaus; Robert S Dieter; Emily Bontekoe; Debra Hoppensteadt; Jawed Fareed
Journal:  Clin Appl Thromb Hemost       Date:  2022 Jan-Dec       Impact factor: 2.389

10.  Multiscale Modeling of Cardiovascular Function Predicts That the End-Systolic Pressure Volume Relationship Can Be Targeted via Multiple Therapeutic Strategies.

Authors:  Kenneth S Campbell; Brianna Sierra Chrisman; Stuart G Campbell
Journal:  Front Physiol       Date:  2020-08-19       Impact factor: 4.566

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.